CoChat

Cytokine-Hormone Interactions: Tumor Necrosis Factor α Impairs Biologic Activity and Downstream Activation Signals of the Insulin-Like Growth Factor I Receptor in Myoblasts

Open access
Broussard, Suzanne R., MCCusker, Robert H., Novakofski, Jan E., Strle, Klemen, Hong Shen, Wen, Johnson, Rodney W., Freund, Gregory G., Dantzer, Robert, Kelley, Keith W. · 2003 · Endocrinology
Cited by 114

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

TNFα is elevated following damage to skeletal muscle. Here we provide evidence that TNFα acts on muscle cells to induce a state of IGF-I receptor resistance. We establish that TNFα inhibits IGF-I-stimulated protein synthesis in primary porcine myoblasts. Similar results were observed in C2C12 murine myoblasts, where as little as 0.01 ng/ml TNFα significantly inhibits protein synthesis induced by IGF-I. TNFα also impairs the ability of IGF-I to induce expression of a key myogenic transcription factor, myogenin. The inhibition by TNFα of IGF-I-induced protein synthesis and expression of myogenin is not due to direct killing of myoblasts by TNFα. Although IGF-I induces an approximately 19-fold induction in tyrosine phosphorylation of the β-chains of its receptor, TNFα does not inhibit this autophosphorylation. Instead, TNFα significantly reduces by approximately 50% IGF-I-stimulated tyrosine phosphorylation of two of the major downstream receptor docking molecules, insulin receptor substrate (IRS)-1 and IRS-2. These results establish that low picogram concentrations of TNFα acts on both porcine and murine myoblasts to impair tyrosine phosphorylation of both IRS-1 and IRS-2, but not the receptor itself. These data are consistent with the notion that very low physiological concentrations of TNFα interfere with both protein synthesis and muscle cell development by inducing a state of IGF-I receptor resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2003-0087

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 50

  1. Blalock, 2002, Harnessing a neural-immune circuit to control inflammation and shock, J Exp Med, 195, F25, 10.1084/jem.20020602 · DOI · Paper page
  2. Savino, 2000, Neuroendocrine control of thymus physiology., Endocr Rev, 21, 412
  3. White, 1998, The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action., Curr Top Microbiol Immunol, 228, 179
  4. Groner, 1995, Prolactin-mediated gene activation in mammary epithelial cells., Curr Opin Genet Dev, 5, 587, 10.1016/0959-437X(95)80027-1 · DOI
  5. Kelly, 2002, The role of prolactin and growth hormone in mammary gland development., Mol Cell Endocrinol, 197, 127, 10.1016/S0303-7207(02)00286-1 · DOI
  6. Blalock, 1984, The immune system as a sensory organ., J Immunol, 132, 1067, 10.4049/jimmunol.132.3.1067 · DOI · Paper page
  7. Novakofski, 2001, Skeletal and Muscular Systems, 454
  8. Grounds, 2002, Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling., Biogerontology, 3, 19, 10.1023/A:1015234709314 · DOI · Paper page
  9. De Rossi, 2000, Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation., Int Immunol, 12, 1329, 10.1093/intimm/12.9.1329 · DOI · Paper page
  10. De Bleecker, 1999, Immunolocalization of tumor necrosis factor-α and its receptors in inflammatory myopathies., Neuromuscul Disord, 9, 239, 10.1016/S0960-8966(98)00126-6 · DOI · Paper page
  11. McNurlan, 1997, Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease., J Clin Invest, 100, 2125, 10.1172/JCI119747 · DOI
  12. Baracos, 2000, Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia., Nutrition, 16, 1015, 10.1016/S0899-9007(00)00407-X · DOI
  13. Broussard, 2001, At the interface of environment-immune interactions: cytokine and growth factor receptors, J Anim Sci, 79, E268, 10.2527/jas2001.79E-SupplE268x · DOI
  14. Venters, 1999, A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide., Proc Natl Acad Sci USA, 96, 9879, 10.1073/pnas.96.17.9879 · DOI · Paper page
  15. Shen, 2002, Proinflammatory cyokines block growth of breast cancer cells by impairing signals from a growth factor receptor., Cancer Res, 62, 4746
  16. Blanton Jr, 1999, Isolation of two populations of myoblasts from porcine skeletal muscle., Muscle Nerve, 22, 43, 10.1002/(SICI)1097-4598(199901)22:1<43::AID-MUS8>3.0.CO;2-O · DOI
  17. Minshall, 1996, Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor., J Immunol, 156, 939, 10.4049/jimmunol.156.3.939 · DOI · Paper page
  18. Strle, 2002, IL-10 promotes survival of microglia without activating Akt., J Neuroimmunol, 122, 9, 10.1016/S0165-5728(01)00444-1 · DOI
  19. Frost, 1997, Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis., Endocrinology, 138, 4153, 10.1210/endo.138.10.5450 · DOI · Paper page
  20. Stewart, 1996, Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts., J Biol Chem, 271, 11330, 10.1074/jbc.271.19.11330 · DOI · Paper page
  21. Meadows, 2000, Tumor necrosis factor-α-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts., J Cell Physiol, 183, 330, 10.1002/(SICI)1097-4652(200006)183:3<330::AID-JCP5>3.0.CO;2-N · DOI · Paper page
  22. Foulstone, 2001, Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF α-induced apoptosis., J Cell Physiol, 189, 207, 10.1002/jcp.10017 · DOI · Paper page
  23. Guttridge, 2000, NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia., Science, 289, 2363, 10.1126/science.289.5488.2363 · DOI · Paper page
  24. Liu, 1993, Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)., Cell, 75, 59
  25. Nabeshima, 1993, Myogenin gene disruption results in perinatal lethality because of severe muscle defect., Nature, 364, 532, 10.1038/364532a0 · DOI · Paper page
  26. Myer, 2001, MyoD cannot compensate for the absence of myogenin during skeletal muscle differentiation in murine embryonic stem cells., Dev Biol, 229, 340, 10.1006/dbio.2000.9985 · DOI
  27. Florini, 1991, Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression., Mol Endocrinol, 5, 718, 10.1210/mend-5-5-718 · DOI · Paper page
  28. Grounds, 1999, Muscle regeneration: molecular aspects and therapeutic implications., Curr Opin Neurol, 12, 535, 10.1097/00019052-199910000-00007 · DOI · Paper page
  29. Musaro, 1999, Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I., Mol Cell Biol, 19, 3115, 10.1128/MCB.19.4.3115 · DOI · Paper page
  30. Miller, 1988, Tumor necrosis factor inhibits human myogenesis in vitro., Mol Cell Biol, 8, 2295, 10.1128/MCB.8.6.2295 · DOI · Paper page
  31. Langen, 2001, Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κB., FASEB J, 15, 1169, 10.1096/fj.00-0463 · DOI · Paper page
  32. Layne, 1999, Tumor necrosis factor-α and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts., Exp Cell Res, 249, 177, 10.1006/excr.1999.4465 · DOI · Paper page
  33. Szalay, 1997, TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin., Eur J Cell Biol, 74, 391
  34. Kelley, 1998, Insulin growth factor-I inhibits apoptosis in hematopoietic progenitor cells. Implications in thymic aging., Ann NY Acad Sci, 840, 518, 10.1111/j.1749-6632.1998.tb09590.x · DOI · Paper page
  35. Cheng, 2000, Functional inactivation of the IGF-I receptor delays differentiation of skeletal muscle cells., J Endocrinol, 167, 175, 10.1677/joe.0.1670175 · DOI
  36. Navarro, 1997, Insulin-like growth factor I (IGF-I) receptor overexpression abolishes the IGF requirement for differentiation and induces a ligand-dependent transformed phenotype in C2 inducible myoblasts., Endocrinology, 138, 5210, 10.1210/endo.138.12.5598 · doi:10.1210/endo.138.12.5598
  37. Storz, 1999, Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake., Eur J Biochem, 266, 17, 10.1046/j.1432-1327.1999.00809.x · DOI · Paper page
  38. Coolican, 1997, The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways., J Biol Chem, 272, 6653, 10.1074/jbc.272.10.6653 · DOI · Paper page
  39. Kaliman, 1998, Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells., Mol Endocrinol, 12, 66, 10.1210/mend.12.1.0047 · DOI · Paper page
  40. Sarbassov, 1998, Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation., Mol Endocrinol, 12, 1870, 10.1210/mend.12.12.0205 · DOI
  41. Tamemoto, 1994, Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1., Nature, 372, 182, 10.1038/372182a0 · DOI · Paper page
  42. Pete, 1999, Postnatal growth responses to insulin-like growth factor I in insulin receptor substrate-1-deficient mice., Endocrinology, 140, 5478, 10.1210/endo.140.12.7219 · DOI · Paper page
  43. White, 1998, The IRS-signalling system: a network of docking proteins that mediate insulin action., Mol Cell Biochem, 182, 3, 10.1023/A:1006806722619 · DOI · Paper page
  44. Goldstein, 2002, Protein-tyrosine phosphatases: emerging targets for therapeutic intervention in type 2 diabetes and related states of insulin resistance., J Clin Endocrinol Metab, 87, 2474, 10.1210/jcem.87.6.8641 · doi:10.1210/jcem.87.6.8641
  45. Goldstein, 2000, Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein., J Biol Chem, 275, 4283, 10.1074/jbc.275.6.4283 · DOI · Paper page
  46. Gao, 2002, Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex., J Biol Chem, 277, 48115, 10.1074/jbc.M209459200 · DOI · Paper page
  47. Zhande, 2002, Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1., Mol Cell Biol, 22, 1016, 10.1128/MCB.22.4.1016-1026.2002 · DOI · Paper page
  48. Arnold, 1998, Muscle differentiation: more complexity to the network of myogenic regulators., Curr Opin Genet Dev, 8, 539, 10.1016/S0959-437X(98)80008-7 · DOI · Paper page
  49. Venuti, 1995, Myogenin is required for late but not early aspects of myogenesis during mouse development., J Cell Biol, 128, 563, 10.1083/jcb.128.4.563 · DOI · Paper page
  50. Hasty, 1993, Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene., Nature, 364, 501, 10.1038/364501a0 · DOI · Paper page

Cited by

See all 114

Metadata

Authors
Broussard, S. R., MCCusker, R. H., Novakofski, J. E., Strle, K., Hong Shen, W., Johnson, R. W., Freund, G. G., Dantzer, R., & Kelley, K. W.
Venue
Endocrinology
Published
2003-07-01
Volume
144
Issue
7
Pages
2988-2996
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2171872390
Cited by
114
References
10
FWCI
3.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.